These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26512636)
1. Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit. Wu C; Wang M; Tang Q; Luo R; Chen L; Zheng P; Zhu W Molecules; 2015 Oct; 20(10):19361-71. PubMed ID: 26512636 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, Biological Evaluation and Docking Studies of Sorafenib Derivatives N-(3-fluoro-4-(pyridin-4-yloxy)phenyl)-4(5)-phenylpicolinamides. Wang M; Wu C; Xu S; Zhu Y; Li W; Zheng P; Zhu W Med Chem; 2017; 13(2):176-185. PubMed ID: 27855595 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit. Wang M; Xu S; Wu C; Liu X; Tao H; Huang Y; Liu Y; Zheng P; Zhu W Bioorg Med Chem Lett; 2016 Nov; 26(22):5450-5454. PubMed ID: 27777009 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, activity and docking studies of phenylpyrimidine-carboxamide Sorafenib derivatives. Wang W; Wu C; Wang J; Luo R; Wang C; Liu X; Li J; Zhu W; Zheng P Bioorg Med Chem; 2016 Dec; 24(23):6166-6173. PubMed ID: 28340913 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold. Wang M; Xu S; Lei H; Wang C; Xiao Z; Jia S; Zhi J; Zheng P; Zhu W Bioorg Med Chem; 2017 Oct; 25(20):5754-5763. PubMed ID: 28927801 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents. Yao J; He Z; Chen J; Sun W; Fang H; Xu W Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antitumor activities of novel benzyl urea analogues of sorafenib. Lu CS; Tang K; Li Y; Jin B; Yin DL; Ma C; Chen XG; Huang HH Yao Xue Xue Bao; 2013 May; 48(5):709-17. PubMed ID: 23888694 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents. Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318 [TBL] [Abstract][Full Text] [Related]
9. [Design, synthesis and antitumor activity of sorafenib analogues containing 2-picolinylhydrazide moiety]. Qin AF; Li Y; Song HR; Chen XG; Jin XF; Wang K; Zhang LJ; Huo LC; Feng ZQ Yao Xue Xue Bao; 2012 Dec; 47(12):1623-9. PubMed ID: 23460968 [TBL] [Abstract][Full Text] [Related]
10. [Synthesis and in vitro cytotoxic activities of sorafenib derivatives]. Wang K; Li Y; Zhang LJ; Yang HZ; Chen XG; Feng ZQ Yao Xue Xue Bao; 2014 May; 49(5):639-43. PubMed ID: 25151734 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors. Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis. El-Miligy MM; Abd El Razik HA; Abu-Serie MM Future Med Chem; 2017 Oct; 9(15):1709-1729. PubMed ID: 28925739 [TBL] [Abstract][Full Text] [Related]
13. [Synthesis and biological evaluation of sorafenib thiourea derivatives]. Yang Z; Fang Z; Wang ZX; Wei P Yao Xue Xue Bao; 2011 Sep; 46(9):1093-7. PubMed ID: 22121780 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel pyrazolo-oxothiazolidine derivatives as antiproliferative agents against human lung cancer cell line A549. Yakaiah S; Sagar Vijay Kumar P; Baby Rani P; Durga Prasad K; Aparna P Bioorg Med Chem Lett; 2018 Feb; 28(4):630-636. PubMed ID: 29395969 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approach. Azimian F; Hamzeh-Mivehroud M; Shahbazi Mojarrad J; Hemmati S; Dastmalchi S Eur J Med Chem; 2020 Sep; 201():112461. PubMed ID: 32663641 [TBL] [Abstract][Full Text] [Related]
16. Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf. Chen KF; Tai WT; Huang JW; Hsu CY; Chen WL; Cheng AL; Chen PJ; Shiau CW Eur J Med Chem; 2011 Jul; 46(7):2845-51. PubMed ID: 21531053 [TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Biological Evaluation of a New Series of 1-Aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea Derivatives as Antiproliferative Agents. Zhang C; Tan X; Feng J; Ding N; Li Y; Jin Z; Meng Q; Liu X; Hu C Molecules; 2019 Jun; 24(11):. PubMed ID: 31167363 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and molecular docking of novel indole scaffold-based VEGFR-2 inhibitors as targeted anticancer agents. Roaiah HM; Ghannam IAY; Ali IH; El Kerdawy AM; Ali MM; Abbas SE; El-Nakkady SS Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29323750 [TBL] [Abstract][Full Text] [Related]
19. Discovery of a Nanomolar Multikinase Inhibitor (KST016366): A New Benzothiazole Derivative with Remarkable Broad-Spectrum Antiproliferative Activity. El-Damasy AK; Cho NC; Nam G; Pae AN; Keum G ChemMedChem; 2016 Aug; 11(15):1587-95. PubMed ID: 27405013 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors. Tu Y; OuYang Y; Xu S; Zhu Y; Li G; Sun C; Zheng P; Zhu W Bioorg Med Chem; 2016 Apr; 24(7):1495-503. PubMed ID: 26906472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]